PROT fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Proteonomix, Inc. is a biotechnology company, which engages in the discovery and development of stem cell therapeutic and cosmeceutical products. It develops pre-clinical stage therapeutic agents and treatments for diabetes, heart, and lung diseases. The company was founded by Michael Moshe Cohen on June 26, 1995 and is headquartered in Paramus, NJ.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
PROT has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company